We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+25.3%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$120M
AUM Growth
-$56.2M
Cap. Flow
+$34.6M
Cap. Flow %
28.84%
Top 10 Hldgs %
89.81%
Holding
32
New
8
Increased
5
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$6.56M
2
MRNA icon
Moderna
MRNA
+$5.05M
3
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$3.04M
4
BHVN icon
Biohaven
BHVN
+$2.9M
5
ARDX icon
Ardelyx
ARDX
+$1.3M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$15.2M
2
WGS icon
GeneDx Holdings
WGS
+$3.95M
3
OPK icon
Opko Health
OPK
+$2.95M
4
IBRX icon
ImmunityBio
IBRX
+$1.57M
5
AXDX
Accelerate Diagnostics
AXDX
+$634K

Sector Composition

Rank Sector Weight
1 Healthcare 93.02%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.14B
$42.8M 35.68%
499,263
– –
PACB icon
2
Pacific Biosciences
PACB
$432M
$17.6M 14.7%
2,154,807
+761,642
+55% +$6.56M
AGEN
3
Agenus
AGEN
$275M
$11.7M 9.79%
249,190
+20,360
+9% +$1.03M
BHVN icon
4
Biohaven
BHVN
$2.07B
$8.42M 7.03%
606,776
+205,555
+51% +$2.9M
BCRX icon
5
BioCryst Pharmaceuticals
BCRX
$2.48B
$6.72M 5.6%
585,194
-50,000
-8% -$624K
MRNA icon
6
Moderna
MRNA
$22.1B
$5.55M 4.63%
+30,900
New +$5.05M
OPK icon
7
Opko Health
OPK
$1.25B
$4.04M 3.37%
3,230,288
-1,872,468
-37% -$2.95M
FORA
8
DELISTED
Forian
FORA
$3.69M 3.08%
1,351,257
-57,175
-4% -$175K
MRNA icon
9
CALL
Moderna
MRNA
$22.1B
$3.65M 3.05%
+172,100
New +$28.1M
TQQQ icon
10
ProShares UltraPro QQQ
TQQQ
$30.5B
$3.46M 2.89%
400,000
+300,000
+300% +$3.04M
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.19M 2.66%
70,453
-235,176
-77% -$15.2M
IMMP
12
Immutep
IMMP
$57M
$2.52M 2.11%
1,442,325
-115,000
-7% -$228K
ARDX icon
13
Ardelyx
ARDX
$1.25B
$2.19M 1.83%
+769,230
New +$1.3M
AXDX
14
DELISTED
Accelerate Diagnostics
AXDX
$1.15M 0.96%
162,808
-58,079
-26% -$634K
THC icon
15
CALL
Tenet Healthcare
THC
$22.6B
$686K 0.57%
+75,000
New +$3.47M
BIIB icon
16
Biogen
BIIB
$30.4B
$668K 0.56%
2,412
– –
WGS icon
17
GeneDx Holdings
WGS
$1.84B
$657K 0.55%
75,455
-179,209
-70% -$3.95M
PFE icon
18
CALL
Pfizer
PFE
$144B
$399K 0.33%
+200,000
New +$9.59M
DMTK
19
DELISTED
DermTech, Inc. Common Stock
DMTK
$338K 0.28%
190,769
+14,200
+8% +$37.8K
AWH
20
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$242K 0.2%
48,540
– –
BHVN icon
21
CALL
Biohaven
BHVN
$2.07B
$103K 0.09%
+50,000
New +$706K
VTNR
22
CALL
DELISTED
Vertex Energy, Inc
VTNR
$41.3K 0.03%
+100,000
New +$747K
PACB icon
23
CALL
Pacific Biosciences
PACB
$432M
$21K 0.02%
+70,000
New +$603K
MRTX
24
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.75K ﹤0.01%
75,000
-25,000
-25% -$1.62M
AGEN
25
CALL
Agenus
AGEN
$275M
– –
-8,437
Closed -$4K
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Oracle Investment Management held 32 positions worth $120M, down 32% from $176M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Oracle Investment Management deployed $34.6M of net new capital in Q4 2022, opening 8 new positions and adding to 5 existing holdings. Its largest new stake was Moderna: 30,900 shares worth $5.55M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 98% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Mirati Therapeutics, Inc. Common Stock, an estimated $15.2M trimmed.

  • Oracle Investment Management's largest Q4 2022 buy was Moderna: 30,900 shares worth $5.55M.
  • Oracle Investment Management added most to Pacific Biosciences in Q4 2022, an estimated $6.56M increase.
  • Oracle Investment Management's biggest Q4 2022 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $15.2M.
  • Oracle Investment Management fully exited ImmunityBio in Q4 2022, selling an estimated $1.57M.
  • Oracle Investment Management's ten largest holdings make up 90% of its $120M portfolio in Q4 2022.
  • Oracle Investment Management opened 8 new positions and closed 8 in Q4 2022.
  • Oracle Investment Management's portfolio value fell 32% quarter-over-quarter to $120M.

Based on Oracle Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.